Explore more publications!
Massachusetts Healthcare Journal
Got News to Share?

Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on October 14, 2025

Gainwell Technologies Launches Rural Health Transformation Collaborative
October 14, 2025

Gainwell Technologies Launches Rural Health Transformation Collaborative

Indeterminate GlobeNewswire
Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease
October 14, 2025

Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease

Indeterminate GlobeNewswire
Vireo Growth Inc. Announces Closing of Acquisition of Outstanding Senior Secured Convertible Notes of Schwazze
October 14, 2025

Vireo Growth Inc. Announces Closing of Acquisition of Outstanding Senior Secured Convertible Notes of Schwazze

Indeterminate GlobeNewswire
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
October 14, 2025

Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference

Indeterminate GlobeNewswire
LB Pharmaceuticals Appoints James Rawls, Pharm.D., as Senior Vice President of Regulatory Affairs
October 14, 2025

LB Pharmaceuticals Appoints James Rawls, Pharm.D., as Senior Vice President of Regulatory Affairs

Indeterminate GlobeNewswire
FibroBiologics to Present at the 2025 ThinkEquity Conference
October 14, 2025

FibroBiologics to Present at the 2025 ThinkEquity Conference

Indeterminate GlobeNewswire
Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research
October 14, 2025

Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research

Indeterminate GlobeNewswire
Profound Medical to Participate in the Stifel 2025 Healthcare Conference
October 14, 2025

Profound Medical to Participate in the Stifel 2025 Healthcare Conference

Indeterminate GlobeNewswire
As "Uptober" Ignites Crypto Market, Bonk, Inc. Revs Up Its Revenue-Generating Engine
October 14, 2025

As "Uptober" Ignites Crypto Market, Bonk, Inc. Revs Up Its Revenue-Generating Engine

Indeterminate GlobeNewswire
Flare Therapeutics to Present FX-909 Phase 1A Data in Oral Presentation at Upcoming AACR-NCI-EORTC International Conference
October 14, 2025

Flare Therapeutics to Present FX-909 Phase 1A Data in Oral Presentation at Upcoming AACR-NCI-EORTC International Conference

Indeterminate GlobeNewswire
IMUNON to Present Phase 3 Ovarian Cancer Study of IMNN-001 at ESMO Congress
October 14, 2025

IMUNON to Present Phase 3 Ovarian Cancer Study of IMNN-001 at ESMO Congress

Indeterminate GlobeNewswire
Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.
October 14, 2025

Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.

Indeterminate GlobeNewswire
4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
October 14, 2025

4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference

Indeterminate GlobeNewswire
SpyGlass Pharma’s Novel BIM-IOL System Demonstrated a Statistically Significant Reduction in Mean IOP at 24 Months
October 14, 2025

SpyGlass Pharma’s Novel BIM-IOL System Demonstrated a Statistically Significant Reduction in Mean IOP at 24 Months

Indeterminate GlobeNewswire
Confluent Health Strengthens National Network with Addition of Commonwealth Hand & Physical Therapy
October 14, 2025

Confluent Health Strengthens National Network with Addition of Commonwealth Hand & Physical Therapy

Indeterminate GlobeNewswire
Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel
October 14, 2025

Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel

Indeterminate GlobeNewswire
NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy
October 14, 2025

NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy

Indeterminate GlobeNewswire
Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
October 14, 2025

Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress

Indeterminate GlobeNewswire
Halda Therapeutics Announces Oral Plenary Presentation on HLD-0915 Clinical Data in Metastatic Castration-Resistant Prostate Cancer (mCRPC) at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics on October 24, 2025
October 14, 2025

Halda Therapeutics Announces Oral Plenary Presentation on HLD-0915 Clinical Data in Metastatic Castration-Resistant Prostate Cancer (mCRPC) at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics on October 24, 2025

Indeterminate GlobeNewswire
Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025
October 14, 2025

Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions